Position statement on priorities for artificial intelligence in GI endoscopy: a report by the ASGE Task Force - 21/09/20
Abstract |
Artificial intelligence (AI) in GI endoscopy holds tremendous promise to augment clinical performance, establish better treatment plans, and improve patient outcomes. Although there are promising initial applications and preliminary clinical data for AI in gastroenterology, the field is still in a very early phase, with limited clinical use. The American Society for Gastrointestinal Endoscopy has convened an AI Task Force to develop guidance around clinical implementation, testing/validating algorithms, and building pathways for successful implementation of AI in GI endoscopy. This White Paper focuses on 3 areas: (1) priority use cases for development of AI algorithms in GI, both for specific clinical scenarios and for streamlining clinical workflows, quality reporting, and practice management; (2) data science priorities, including development of image libraries, and standardization of methods for storing, sharing, and annotating endoscopic images/video; and (3) research priorities, focusing on the importance of high-quality, prospective trials measuring clinically meaningful patient outcomes.
Le texte complet de cet article est disponible en PDF.Abbreviations : AI, ASGE, CADe, CADx, EHR, ML
Plan
| DISCLOSURE: The following authors disclosed financial relationships: T. M. Berzin: Consultant for Boston Scientific, Wision AI, and Medtronic; speaker for Medtronic; research support from Wision AI. M. B. Wallace: Consultant for Virgo Inc, Cosmo/Aries, Anx Robotica, Covidien, GI Supply, Endokey, Endostart, and Microtek; research support from Cosmo/Aries, Ninepoint Medical, Fujifilm, Boston Scientific, Olympus, and Medtronic; stock optins in Virgo Inc; food/beverage reimbursement from Cook Medical and Synergy Pharmaceuticals. S. A. Gross: Consultant for Olympus. A. Repici: Consultant and advisory board for Medtronic and Fujifilm. P. Sharma: Consultant for Olympus, Boston Scientific, Lumendi, Lucid, Bausch, Fujifilm, and Medtronic; research support from Olympus, Fujifilm, Erbe, Medtronic, U.S. Endoscopy, Ironwood, Cosmo Pharmaceuticals, and CDx Labs. All other authors disclosed no financial relationships. |
Vol 92 - N° 4
P. 951-959 - octobre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
